Transcription: A hub of activity

Imaging experiments reveal the complex and dynamic nature of the transcriptional hubs associated with Notch signaling.
  1. Virginia L Pimmett
  2. Mounia Lagha  Is a corresponding author
  1. Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS UMR 5535, France

It is exceedingly rare that a protein acts alone – more often, proteins co-operate with one another so that they can function with greater speed, specificity, or reactivity. The process by which they assemble at promoter regions within the genome in order to initiate gene transcription is relatively well understood. However, much less is known about how proteins come together at enhancer regions – sites that regulate gene expression – and how each protein contributes to transcription.

One form of co-operation involves transcription factors and other regulatory proteins physically associating with one another to form a ‘hub’ – a pocket of high protein concentration – around gene enhancers and promoters in the cell nucleus (Hnisz et al., 2017). But how do these hubs form and evolve over time? How do they ‘sense’ upstream signaling input? And how do they foster transcription? Now, in eLife, Sarah Bray from the University of Cambridge and colleagues – including Javier deHaro-Arbona as first author – report the results of experiments that will help to answer these questions (deHaro-Arbona et al., 2023; Figure 1).

Notch signaling and transcriptional hubs.

(A) The E(spl)-C locus contains multiple genes that are regulated by the Notch signaling pathway. (B) When there is no Notch signal, the transcriptional hub near the E(spl)-C locus is inactive (bottom left): an inactive hub represses gene expression because CSL is in complex with the suppressor protein Hairless. When there is a Notch signal, CSL associates with the Notch intracellular domain (NICD) to create an open hub, which targets Notch-activated genes, and the CSL-NICD complex recruits the co-activator Mastermind to create an engaged hub. A subset of engaged hubs become active (top right) by recruiting a Mediator complex and RNA polymerase II to engage in transcription.

Image credits: Figure created using elements from Biorender.com.

The team focused on the Notch signaling pathway, which becomes activated when a Notch receptor at the plasma membrane of a cell binds to its ligand. This triggers the release of the Notch intracellular domain (NICD) into the cell where it recruits two other proteins: a transcription factor known as CSL, and the co-activator protein Mastermind. Together, with RNA Polymerase II (the protein complex that transcribes DNA) and Mediator (a complex that is also involved in transcription), they regulate the expression of many genes.

To study this process, deHaro-Arbona et al. performed ex vivo imaging of Drosophila larval salivary glands. The experiments looked at a gene locus called E(spl)-C (short for the Enhancer of split Complex), which contains multiple genes that are regulated by Notch signaling. This locus and its regulators (CSL, Mastermind, RNA Polymerase II and Mediator) were each fluorescently labelled and monitored in live cells.

The findings show that Mastermind and CSL form a hub at the E(spl)-C locus when Notch signaling is activated. Intriguingly, the amount of CSL recruited to the hub did not correlate with the number of CSL binding sites at the locus, suggesting that CSL proteins do not interact with these regions in a one-to-one ratio. This more complex type of co-operation, known as non-stoichiometric binding, may be mediated by weak protein-protein interactions. As intrinsically disordered regions in proteins are often implicated in such interactions (Chong et al., 2018), deHaro-Arbona et al. investigated the role of these regions in NICD, CSL and Mastermind. They found that while the disordered region of NICD targeted the E(spl)-C locus, the disordered regions in CSL and Mastermind made only minor contributions to the hub. It appears, therefore, that the hub only partially relies on intrinsically disordered regions.

This is consistent with prior observations that not all hubs are equal and, instead, they consist of local microenvironments of various sizes, compositions and biophysical properties, which are generally dynamic and evolve during transcription (Sharp et al., 2022). Hubs are generally located in places where molecules rely on slower diffusion kinetics to search for their target (Lu and Lionnet, 2021). This is also the case for Notch activator complexes, which exhibited slow diffusion and a long residence time at E(spl)-C.

To examine how the function of the hub depends on its individual components, deHaro-Arbona et al. inhibited the recruitment of the Mastermind protein. This did not impact the recruitment of CSL to the hub. It also did not prevent Notch signalling from increasing chromatin accessibility, suggesting the hub does not need Mastermind in order to access chromatin. However, another protein in the hub, a Mediator complex named Med13, was not recruited. These findings indicate that while some changes induced by Notch signaling can occur independently of Mastermind, it is essential for recruitment of Med13.

Next, deHaro-Arbona et al. investigated how the Notch hubs impact transcription. Live imaging showed that only a third of hubs recruited the Mediator complex and RNA Polymerase II (which enable transcription), and only a third of cells showed active transcription following signaling. This is consistent with the view that even in the presence of all the necessary transcription factors, active transcription is probabilistic (Lu and Lionnet, 2021).

It remains an open question how promoters decode transcriptional hubs to trigger a specific choreography of RNA Polymerase II activation. A transcriptional hub being present does not always result in bursts of transcriptional activity (Dufourt et al., 2018; Mir et al., 2018). In some contexts, a high local density of newly synthesized transcripts can dissolve hubs (Cho and O’Farrell, 2022; Sharp et al., 2022), allowing hubs to self-limit their existence using RNA-mediated feedback mechanisms. The transient nature of hubs could be contributing to the stochasticity of transcription, but this hypothesis warrants more investigation.

Finally, deHaro-Arbona et al. asked if the action of a Notch transcription hub could persist once cells are no longer subject to a Notch input signal. Optogenetics experiments revealed that loci with prior exposure to Notch signaling were re-activated by subsequent Notch signaling more rapidly than naïve cells, thus displaying a form of ‘memory’. deHaro-Arbona et al. propose this memory might arise from the transcription factor CSL ‘book-marking’ the E(spl)-C locus during mitosis in order to speed up transcriptional reactivation, as has been observed in experiments with other transcription factors in vivo (Bellec et al., 2022; Gonzalez et al., 2021). This is clearly a topic for further research.

By revealing the dynamic nature of these transcriptional hubs (Figure 1), the work of deHaro-Arbona et al. leads to a number of questions. How long do hubs take to form at the target locus after signal induction, and how long do they take to dissolve once the signal stops? How does the hub evolve once transcription is activated, and how might that impact the timing and variability of transcriptional activity? Overall, the work enriches our understanding of hub formation and the role of hubs in modulating transcription, and provides a flexible platform to explore the function of transcriptional hubs in living organisms.

References

Article and author information

Author details

  1. Virginia L Pimmett

    Virginia L Pimmett is in the Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS UMR 5535, Montpellier, France

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5786-7989
  2. Mounia Lagha

    Mounia Lagha is in the Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS UMR 5535, Montpellier, France

    For correspondence
    mounia.lagha@igmm.cnrs.fr
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7082-1950

Publication history

  1. Version of Record published: November 29, 2023 (version 1)

Copyright

© 2023, Pimmett and Lagha

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 968
    views
  • 73
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Virginia L Pimmett
  2. Mounia Lagha
(2023)
Transcription: A hub of activity
eLife 12:e93706.
https://doi.org/10.7554/eLife.93706

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Gregory Caleb Howard, Jing Wang ... William P Tansey
    Research Article

    The chromatin-associated protein WD Repeat Domain 5 (WDR5) is a promising target for cancer drug discovery, with most efforts blocking an arginine-binding cavity on the protein called the ‘WIN’ site that tethers WDR5 to chromatin. WIN site inhibitors (WINi) are active against multiple cancer cell types in vitro, the most notable of which are those derived from MLL-rearranged (MLLr) leukemias. Peptidomimetic WINi were originally proposed to inhibit MLLr cells via dysregulation of genes connected to hematopoietic stem cell expansion. Our discovery and interrogation of small-molecule WINi, however, revealed that they act in MLLr cell lines to suppress ribosome protein gene (RPG) transcription, induce nucleolar stress, and activate p53. Because there is no precedent for an anticancer strategy that specifically targets RPG expression, we took an integrated multi-omics approach to further interrogate the mechanism of action of WINi in human MLLr cancer cells. We show that WINi induce depletion of the stock of ribosomes, accompanied by a broad yet modest translational choke and changes in alternative mRNA splicing that inactivate the p53 antagonist MDM4. We also show that WINi are synergistic with agents including venetoclax and BET-bromodomain inhibitors. Together, these studies reinforce the concept that WINi are a novel type of ribosome-directed anticancer therapy and provide a resource to support their clinical implementation in MLLr leukemias and other malignancies.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Rajan M Thomas, Matthew C Pahl ... Andrew D Wells
    Research Article

    Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.